Acute leukemias after treatment with radioiodine for thyroid cancer
Roldán Schilling, V.; Fernández Abellán, P.; Domínguez Escribano, J.R.; Rivas González, C.; Mut Barberá, E.; Calatayud Cendra, R.
Haematologica 83(8): 767-768
1998
ISSN/ISBN: 0390-6078 PMID: 9793274 Document Number: 490073
Leukemia is an uncommon complication of exposure to radioiodine (131I), used in treatment of thyroid cancer, because low doses are now used. We report two cases of acute myelogenous leukemia developed after the treatment of a thyroid carcinoma with a small dose of 131I.
Document emailed within 1 workday
Related Documents
Grudeva-Popova, J.; Yaneva, M.; Zisov, K.; Ananoshtev, N. 2007: Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review Journal of BUON: Official Journal of the Balkan Union of Oncology 12(1): 129-132Dirr, W.; Pabst, H.W. 1982: Treatment of follicular thyroid cancer with radioiodine Schweizerische Rundschau für Medizin Praxis 71(13): 562-566
Schober, O.; Günter, H.H.; Schwarzrock, R.; Hundeshagen, H. 1987: Long-term hematologic changes caused by radioiodine treatment of thyroid cancer. I. Peripheral blood changes Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 163(7): 464-474
Bednár, J.; Nĕmec, J.; Soutorová, M.; Neradilová, M.; Pohunková, D.; Zamrazil, V.; Vána, S.; Havelka, J.; Röhling, S. 1979: Labelled amino acids in plasma of patients with thyrotoxicosis and thyroid cancer after radioiodine treatment Endocrinologia Experimentalis 13(1): 53-63
Hasse-Lazar, K.; Handkiewicz-Junak, D.; Roskosz, Józef.; Szpak-Ulczok, S.; Krajewska, J.; Jurecka-Lubieniecka, B.; Jarzab, B. 2006: Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences Endokrynologia Polska 57(4): 445-450
Fu, H.; Ma, C.; Tang, L.; Wu, F.; Liu, B.; Wang, H. 2015: Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(1): 121-128
Górowski, T.; Gabryelewicz, M.B.; Jastrzebska, H. 1992: Anaplastic thyroid carcinoma developed after treatment of "hot" thyroid nodule with radioiodine Endokrynologia Polska 43(3): 308-313
Schiavo, M.; Bagnara, M.C.; Pomposelli, E.; Altrinetti, V.; Calamia, I.; Camerieri, L.; Giusti, M.; Pesce, G.; Reitano, C.; Bagnasco, M.; Caputo, M. 2013: Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(3): 301-307
Horácek, Jí. 2015: Radioiodine therapy in patients with low-thyroid cancer Vnitrni Lekarstvi 61(9): 755-757
Dietlein, M.; Dressler, J.; Farahati, J.; Leisner, B.; Moser, E.; Reiners, C.; Schicha, H.; Schober, O. 1999: Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer Nuklearmedizin. Nuclear Medicine 38(6a): 221-222
Saengsuda, Y. 2013: Radioiodine remnant ablation in low-risk differentiated thyroid cancer Journal of the Medical Association of Thailand 96(5): 614-624
Hodak, S.P.; Carty, S.E. 2009: Radioiodine-resistant differentiated thyroid cancer: hope for the future Oncology 23(9): 775-776
Salvia, A.; Licata, G. 1971: Behavior of the radioiodine thyroid test after treatment with HCG Bollettino della Societa Italiana di Biologia Sperimentale 47(10): 285-288
Schachter, D.; Atria, A.; Pineda, G. 1986: The autonomous thyroid nodule: results of treatment with radioiodine Revista Medica de Chile 114(3): 228-231
Łabuzek, K.; Kukla, U.; Chronowska, J.; Madej, P.ł; Okopień Bogusław 2014: Radioiodine--today's trends in treatment of benign thyroid diseases Wiadomosci Lekarskie 67(2 Part 1): 80-84
Konrády, Aás. 2002: Radioiodine treatment of differentiated thyroid carcinomas: residual ablation Orvosi Hetilap 143(25): 1557; Author Reply
Sumimura, J.; Nakagawa, K.; Kawamura, J.; Tayama, M.; Takahashi, E.; Moritomo, T.; Miyata, M. 1990: Thyroid cancer metastasis to the lumbar spine successfully treated by embolization and radioiodine. A case report Nihon Geka Gakkai Zasshi 91(7): 910-913
Cimino, G.; Rapanotti, M.C.; Biondi, A.; Elia, L.; Lo Coco, F.; Price, C.; Rossi, V.; Rivolta, A.; Canaani, E.; Croce, C.M.; Mandelli, F.; Greaves, M. 1997: Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias Cancer Research 57(14): 2879-2883
Sriprapaporn, J.; Sethanandha, C.; Yingsa-nga, T.; Komoltri, C.; Thongpraparn, T.; Harnnanthawiwai, C. 2015: Utility of Adding SPECT/CT Imaging to Post-Therapeutic Radioiodine Whole-Body Scan in Patients with Differentiated Thyroid Cancer Journal of the Medical Association of Thailand 98(6): 596-605
Thientunyakit, T.; Pusuwan, P.; Tuchinda, P.; Khiewvan, B.; Kiewvan, B. 2013: The correlation of post-operative radioiodine uptake and Tc-99m pertechnetate thyroid scintigraphy and the result of thyroid remnant ablation Journal of the Medical Association of Thailand 96(9): 1199-1207